333 related articles for article (PubMed ID: 31682328)
1. Comorbid anxiety in late-life depression: Relationship with remission and suicidal ideation on venlafaxine treatment.
Saade YM; Nicol G; Lenze EJ; Miller JP; Yingling M; Wetherell JL; Reynolds CF; Mulsant BH
Depress Anxiety; 2019 Dec; 36(12):1125-1134. PubMed ID: 31682328
[TBL] [Abstract][Full Text] [Related]
2. Suicide ideation and male-female differences in major depressive disorder.
Olgiati P; Pecorino B; Serretti A
Int J Psychiatry Clin Pract; 2024 Mar; 28(1):53-62. PubMed ID: 38587055
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity.
Lyndon GJ; Prieto R; Wajsbrot DB; Allgulander C; Bandelow B
Int Clin Psychopharmacol; 2019 May; 34(3):110-118. PubMed ID: 30870236
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older Adults.
Smagula SF; Butters MA; Anderson SJ; Lenze EJ; Dew MA; Mulsant BH; Lotrich FE; Aizenstein H; Reynolds CF
JAMA Psychiatry; 2015 Oct; 72(10):1021-8. PubMed ID: 26288246
[TBL] [Abstract][Full Text] [Related]
5. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
[TBL] [Abstract][Full Text] [Related]
6. Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
Kircanski K; Williams LM; Gotlib IH
Depress Anxiety; 2019 Jan; 36(1):63-71. PubMed ID: 30311742
[TBL] [Abstract][Full Text] [Related]
7. Putative Antidepressant Effect of Chamomile (
Amsterdam JD; Li QS; Xie SX; Mao JJ
J Altern Complement Med; 2020 Sep; 26(9):813-819. PubMed ID: 31808709
[No Abstract] [Full Text] [Related]
8. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF
JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
[TBL] [Abstract][Full Text] [Related]
9. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
Leblé N; Radon L; Rabot M; Godart N
Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
[TBL] [Abstract][Full Text] [Related]
10. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
11. Effect of Metabolic Syndrome on Late-Life Depression: Associations with Disease Severity and Treatment Resistance.
Mulvahill JS; Nicol GE; Dixon D; Lenze EJ; Karp JF; Reynolds CF; Blumberger DM; Mulsant BH
J Am Geriatr Soc; 2017 Dec; 65(12):2651-2658. PubMed ID: 29235659
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
[TBL] [Abstract][Full Text] [Related]
13. Anxiolytic effects of venlafaxine/olanzapine combination in treatment of anxious depression.
Kulhan T; Marcincakova Husarova V; Ondrejka I; Farsky I; Nosalova G
Neuro Endocrinol Lett; 2018 Feb; 38(8):579-585. PubMed ID: 29504736
[TBL] [Abstract][Full Text] [Related]
14. Predicting Remission in Late-Life Major Depression: A Clinical Algorithm Based Upon Past Treatment History.
Buchalter ELF; Oughli HA; Lenze EJ; Dixon D; Miller JP; Blumberger DM; Karp JF; Reynolds CF; Mulsant BH
J Clin Psychiatry; 2019 Dec; 80(6):. PubMed ID: 31846575
[TBL] [Abstract][Full Text] [Related]
15. The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment.
Saveanu R; Etkin A; Duchemin AM; Goldstein-Piekarski A; Gyurak A; Debattista C; Schatzberg AF; Sood S; Day CV; Palmer DM; Rekshan WR; Gordon E; Rush AJ; Williams LM
J Psychiatr Res; 2015 Feb; 61():1-12. PubMed ID: 25586212
[TBL] [Abstract][Full Text] [Related]
16. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
[TBL] [Abstract][Full Text] [Related]
17. Dimensions of anxiety in Major depressive disorder and their use in predicting antidepressant treatment outcome: an iSPOT-D report.
Braund TA; Palmer DM; Williams LM; Harris AWF
Psychol Med; 2020 Apr; 50(6):1032-1042. PubMed ID: 31023398
[TBL] [Abstract][Full Text] [Related]
18. Treatment Emergent Suicidal Ideation in depressed older adults.
Cristancho P; O'Connor B; Lenze EJ; Blumberger DM; Reynolds CF; Dixon D; Mulsant BH
Int J Geriatr Psychiatry; 2017 Jun; 32(6):596-604. PubMed ID: 27162147
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults.
Marshe VS; Maciukiewicz M; Rej S; Tiwari AK; Sibille E; Blumberger DM; Karp JF; Lenze EJ; Reynolds CF; Kennedy JL; Mulsant BH; Müller DJ
Am J Psychiatry; 2017 May; 174(5):468-475. PubMed ID: 28068779
[TBL] [Abstract][Full Text] [Related]
20. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
